000 01150 a2200277 4500
005 20250517054505.0
264 0 _c20180213
008 201802s 0 0 eng d
022 _a1477-092X
024 7 _a10.1177/1078155215608522
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLoboda, C
245 0 0 _aIncompatibility of busulfan with 1 ml Luer-Lock syringes.
_h[electronic resource]
260 _bJournal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
_cJun 2016
300 _a571-2 p.
_bdigital
500 _aPublication Type: Letter
650 0 4 _aAntineoplastic Agents, Alkylating
_xadverse effects
650 0 4 _aBusulfan
_xadverse effects
650 0 4 _aHumans
650 0 4 _aPolymers
_xadverse effects
650 0 4 _aSyringes
_xadverse effects
700 1 _aLider, P
700 1 _aVigneron, J
773 0 _tJournal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
_gvol. 22
_gno. 3
_gp. 571-2
856 4 0 _uhttps://doi.org/10.1177/1078155215608522
_zAvailable from publisher's website
999 _c25313450
_d25313450